Qube Research & Technologies (QRT)
CGEM icon

Qube Research & Technologies (QRT)’s Cullinan Oncology CGEM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Sell
19,936
-70,380
-78% -$1.05M ﹤0.01% 2742
2026
Q1 		$1.28M Sell
90,316
-28,976
-24% -$372K ﹤0.01% 2384
2025
Q4 		$1.23M Sell
119,292
-33,117
-22% -$299K ﹤0.01% 2467
2025
Q3 		$904K Buy
152,409
+85,290
+127% +$625K ﹤0.01% 2564
2025
Q2 		$505K Buy
+67,119
New +$539K ﹤0.01% 2689
2025
Q1 		– Sell
-13,609
Closed -$166K – 3529
2024
Q4 		$166K Buy
+13,609
New +$196K ﹤0.01% 2881
2024
Q3 		– Sell
-190,520
Closed -$3.32M – 3397
2024
Q2 		$3.32M Buy
190,520
+75,408
+66% +$1.61M 0.01% 1443
2024
Q1 		$1.96M Buy
115,112
+108,266
+1,581% +$1.67M ﹤0.01% 1773
2023
Q4 		$69.8K Buy
+6,846
New +$60.6K ﹤0.01% 3213
2022
Q2 		– Sell
-16,628
Closed -$174K – 2555
2022
Q1 		$174K Sell
16,628
-13,524
-45% -$183K ﹤0.01% 1978
2021
Q4 		$465K Buy
+30,152
New +$601K ﹤0.01% 1607

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CGEM Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Cullinan Oncology (CGEM) stake by 78% in Q2 2026, selling an estimated $1.05M and leaving 19,936 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #2742.

Qube Research & Technologies (QRT) first reported a position in CGEM in Q4 2021 and has held it in 11 quarters since. The position peaked at $3.32M in Q2 2024. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Qube Research & Technologies (QRT) held 19,936 shares of Cullinan Oncology worth $363K as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 70,380 Cullinan Oncology shares in Q2 2026, an estimated $1.05M.
  • Cullinan Oncology made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2742 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cullinan Oncology in Q4 2021 and has held it in 11 quarters since.
  • Qube Research & Technologies (QRT)'s Cullinan Oncology position peaked at $3.32M in Q2 2024.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.